R89H (p.Arg89His) variant of INS (Insulin)
R89H (p.Arg89His) in INS (Insulin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of Hyperproinsulinemia; Type 1 diabetes mellitus 2; Diabetes mellitus, permanent ne. The available variant effect predictions contribute to a CATVariant prioritization score of 0.74 / 1. The record also includes population frequency data, published literature, and structural context.
R89H (p.Arg89His) variant details
- p.Arg89His
- rs28933985
- ClinGen CA123079
- ClinVar RCV000014310
- ClinVar RCV001091846
- Pathogenic/Likely pathogenic
- Hyperproinsulinemia; Type 1 diabetes mellitus 2; Diabetes mellitus, permanent ne
- Missense
- Variant Prioritization Score for Impact Estimate 0.745
- REVEL 0.79
- ESM-1b 1.00
- AlphaMissense 0.61
- MetaLR 0.81
- MetaSVM 0.77
- CADD 25.20
- ClinVar: Pathogenic/Likely pathogenic (Hyperproinsulinemia; Type 1 diabetes mellitus 2; Diabetes mellit)
- EBI: Pathogenic (in HPRI)
- UniProt: Pathogenic (in HPRI)
- Most common in the Non-Finnish European population (allele frequency 2.9e-05)
- Structural context available
- Cited in: Two unrelated patients with familial hyperproinsulinemia due to a mutation substituting histidine for arginine at… (PMID 2196279)
- Cited in: Posttranslational cleavage of proinsulin is blocked by a point mutation in familial hyperproinsulinemia. (PMID 4019786)